In contrast, for practices where clinical guidelines favor AS, a smaller panel of markers with high PPV for cancer (BRAF V600E single-gene test or seven-gene panel) may suffice for selecting nodules that warrant resection. The gene discussed is BRAF; the disease is cancer.